Christoph Von Petersdorff
About Christoph Von Petersdorff
Christoph Von Petersdorff is the Business Unit Director of Innovative Medicine at Bristol Myers Squibb in Vienna, Austria, with over two decades of experience in the pharmaceutical industry.
Current Position at Bristol Myers Squibb
Christoph Von Petersdorff is currently serving as the Business Unit Director, Innovative Medicine at Bristol Myers Squibb in Vienna, Austria. His role involves overseeing the development and implementation of strategies to drive innovation and business growth within the company’s portfolio of innovative medicines. His extensive experience in brand management contributes to his effectiveness in this high-impact role.
Previous Roles at Novartis
Christoph has held various positions at Novartis, spanning different countries and areas of specialization. His roles included Global Brand Future Director from 2022 to 2023 in Basel, Switzerland; Brand Director Dermatology from 2017 to 2022 in Nürnberg, Germany; and Franchise Head Cardiometabolic & Respiratory from 2014 to 2017 in Budapest, Hungary. These roles demonstrate his ability to lead diverse teams and manage complex brand portfolios.
Experience in the Pharmaceutical Industry
With over two decades of experience in the pharmaceutical industry, Christoph has cultivated a broad skill set in brand management and franchise leadership. His career includes significant positions in Germany, Hungary, and Switzerland, where he was instrumental in driving business growth and innovation. His expertise spans multiple therapeutic areas, including dermatology, cardiometabolic, and respiratory franchises.
Early Career at Masterfoods GmbH
Before his extensive career in pharmaceuticals, Christoph worked in the food industry as a District Manager at Masterfoods GmbH from 2004 to 2005 in Stuttgart, Germany. This role marked the beginning of his professional journey, providing him with early experience in management and leadership within a different sector.
Educational Background
Christoph holds a Master of Business Administration (MBA) from Universität Passau, where he studied from 1997 to 2003. His educational background provided the foundational knowledge and skills that have supported his successful career in the pharmaceutical industry.